(Post-pandemic Era)-Global Opioid Induced Constipation (OIC) Drugs Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report Code : XYZ2131779
Published On: Nov, 2020
Category : Medical Devices
Pages : 110

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Opioid Induced Constipation (OIC) Drugs market in this environment.

In terms of revenue, this research report indicated that the global Opioid Induced Constipation (OIC) Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Opioid Induced Constipation (OIC) Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Ironwood Pharmaceuticals Inc aims at producing XX Opioid Induced Constipation (OIC) Drugs in 2020, with XX % production to take place in global market, Daiichi Sankyo Co Ltd accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Opioid Induced Constipation (OIC) Drugs Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Opioid Induced Constipation (OIC) Drugs Market
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

Major Type of Opioid Induced Constipation (OIC) Drugs Covered in report:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Application Segments Covered in report
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

For any other requirements, please feel free to contact us and we will provide you customized report.
With tables and figures helping analyze worldwide (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Opioid Induced Constipation (OIC) Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope
1.1 Product Details and Introduction
1.1.1 Lubiprostone -Product Introduction and Major Manufacturers
1.1.2 Methyl Naltrexone Bromide -Product Introduction and Major Manufacturers
1.1.3 Naldemedine -Product Introduction and Major Manufacturers
1.1.4 Alvimopan -Product Introduction and Major Manufacturers
1.1.5 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Global Opioid Induced Constipation (OIC) Drugs Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

3 Regional Market Analysis
3.1 China Opioid Induced Constipation (OIC) Drugs Market
3.1.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Opioid Induced Constipation (OIC) Drugs Market
3.2.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Opioid Induced Constipation (OIC) Drugs Market
3.3.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Opioid Induced Constipation (OIC) Drugs Market
3.4.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Opioid Induced Constipation (OIC) Drugs Market
3.5.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market
3.6.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Opioid Induced Constipation (OIC) Drugs Market
3.7.1 Top Companies leading Opioid Induced Constipation (OIC) Drugs Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)

4 Value Chain (Impact of COVID-19)
4.1 Opioid Induced Constipation (OIC) Drugs Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Opioid Induced Constipation (OIC) Drugs Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors

5 Regional Market Forecast (2021-2026)
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2026)
5.2 Global Opioid Induced Constipation (OIC) Drugs Sales Value and Growth Rate (2021-2026)

6 Opioid Induced Constipation (OIC) Drugs Competitive Analysis
6.1 Ironwood Pharmaceuticals Inc
6.1.1 Ironwood Pharmaceuticals Inc Company Profiles
6.1.2 Ironwood Pharmaceuticals Inc Product Introduction
6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Daiichi Sankyo Co Ltd
6.2.1 Daiichi Sankyo Co Ltd Company Profiles
6.2.2 Daiichi Sankyo Co Ltd Product Introduction
6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Pfizer
6.3.1 Pfizer Company Profiles
6.3.2 Pfizer Product Introduction
6.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Progenics Pharmaceuticals Inc
6.4.1 Progenics Pharmaceuticals Inc Company Profiles
6.4.2 Progenics Pharmaceuticals Inc Product Introduction
6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Shionogi & Co., Ltd
6.5.1 Shionogi & Co., Ltd Company Profiles
6.5.2 Shionogi & Co., Ltd Product Introduction
6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Allergan Plc
6.6.1 Allergan Plc Company Profiles
6.6.2 Allergan Plc Product Introduction
6.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Nektar Therapeutics
6.7.1 Nektar Therapeutics Company Profiles
6.7.2 Nektar Therapeutics Product Introduction
6.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Purdue Pharma
6.8.1 Purdue Pharma Company Profiles
6.8.2 Purdue Pharma Product Introduction
6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 S.L.A. Pharma AG
6.9.1 S.L.A. Pharma AG Company Profiles
6.9.2 S.L.A. Pharma AG Product Introduction
6.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Mundipharma International Limited
6.10.1 Mundipharma International Limited Company Profiles
6.10.2 Mundipharma International Limited Product Introduction
6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Ono Pharmaceutical Co., Ltd
6.12 Takeda Pharmaceutical Company Limited
6.13 Theravance Biopharma Inc
6.14 Valeant Pharmaceuticals International
6.15 Cosmo Pharmaceuticals SA
6.16 Daewoong Pharmaceutical
6.17 C.B. Fleet Company
6.18 Sucampo Pharmaceuticals

7 Conclusion
The (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

What trends are influencing the growth of the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market?

New players are entering the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.

What is the expected rate of growth in the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market?

From 2024 to 2029, the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.

Is further segmentation possible given the scope of the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market study?

Yes, the add-on segmentation is available in the premium customised version of the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.

What are the top priorities for the growth of the (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Market?

In this highly competitive and rapidly evolving (Post pandemic Era) Global Opioid Induced Constipation (OIC) Drugs Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.